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 Abstract. To date stress, a highly complex 
process that disrupts homeostasis and involves 
environmental and psychosocial factors, is 
considered as one of the most crucial factor that 
affects our daily life, especially urban dweller's life. 
Clinical and experimental studies widely support 
the notion that adrenergic stimulation due to chronic 
stress affects inflammation and metabolism.  
In this work, supported by several recent 
scientific evidences, we show how stress plays a 
positive role in cancer initiation, progression and 
cancer metastasis, a negative role for anti-tumor 
immune function and therapy response. 
Understanding the intricacies of this interaction 
could provide an additional help on how act in 
cancer prevention and therapy. 
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Inflammation 
 
I.  INTRODUCTION 
 
 In the modern civilization stress is considered as 
one of the most crucial factor that affects our daily life. 
Stress was described for the first time by the 
endocrinologist Hans Seyle in 1936 as the human body’s 
biological response to adverse changes in the environment 
such as physical, mental and social stimuli called 
"stressors". To address and overcome these challenges and 
preserve the wellness our body has evolved a complex 
repertoire of physiologic and behavioral changes leading 
to adaptive stress response [1]. Based on their duration 
and intensity, the stress responses are generally grouped 
into two major types: acute and chronic. Acute stress, 
generally considered to be healthful for the organisms is a 
transient condition while prolonged chronic stress may 
elicit a disruption of internal homeostatic mechanisms. 
Indeed, the human body is able to circumvent and 
normalize the effects of acute stress, but when it becomes 
chronic it can disrupt the optimal body equilibrium. 
Depending on type and severity of the stressors perceived 
by the organism, stress responses are characterized by 
specificity in highly interconnected activation of 
neuroendocrine system. In detail, the hypothalamic-
pituitary-adrenal axis (HPA) and the sympathetic nervous 
system (SNS) are the primary players in the regulation of 
the stress-related cascade [2, 3]. 
Stressors inducing the central and peripheral nervous 
system responses activate HPA that stimulates the release 
of corticotropin-releasing hormone (CRH) and arginine 
vasopressine (AVP) from the paraventricular nucleus of 
the hypothalamus (PVH) which, in turn, enhance the 
anterior pituitary gland to secrete adrenocorticotropic 
hormone (ACTH), encephalin and endorphin (END). 
ACTH mediates the downstream release of 
glucocorticoids (GC) from the adrenal cortex and 
catecholamines, norepinephrine (NE) and epinephrine 
(EPI), from the adrenal medulla. The sustained release of 
these two neuropeptides results in the activation of 
systemic stress-responsive pathways that modulate several 
physiological and biochemical behaviors, including “The 
Fight-or-Flight Response” and regulation of 
thermogenesis and cell survival [2, 3]. Conversely, a 
distressed psychological and physiological state that 
occurs in individuals in the form of fear, anxiety, pain and 
depression can lead to a condition of chronic stress 
bearing adverse effects on cardiovascular and nervous 
systems and exacerbation of autoimmune diseases.  
Moreover, recent epidemiological studies have shown that 
chronic psychological stress plays a positive role in cancer 
initiation, progression and cancer metastasis and a 
negative role for anti-tumor immune function and therapy 
response [4]. It is recognized that psychological stressors 
are associated with a greater cancer incidence, especially 
for breast cancer that is almost ninefold, and at the same 
time with a poor survival in patients with ovarian, 
prostate, lung, head and neck, hepatobiliary and lymphoid 
cancers [4, 5]. 
 
 
II. CHRONIC STRESS: A ROLE IN CELL SURVIVAL, 
TUMOR GROWTH AND METASTASIS FORMATION 
 
 Catecholaminergic neurotransmitters of the acute 
and chronic stress responses bind to a class of seven-
transmembrane, G-coupled protein receptors: α-adrenergic 
receptors (α-ARs) and β-adrenergic receptors (β-ARs).  
Recently many scientific works shown that several tumor 
types including pancreatic, colorectal, oesophagus, 
stomach, lung, breast, ovarian, prostate and nasopharynx 
cancers, as well as in melanoma, pituitary tumors, Ewing 
sarcoma, neuroblastoma, and lymphomas are correlated 
with a non-physiological β-ARs expression [6]. 
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Indeed, various physiological stress model exposing 
rodents to experimental stressors like as fear or anxiety 
have been developed and extensively investigated to 
discover the relationship between β-adrenergic system and 
tumorigenic processes [7].  
Therefore it was possible to observe that, chronic stress 
promotes the release of stress hormones in murine tumor 
models increasing tumor burden and aggressiveness of 
tumor growth [8]. On this light, the molecular 
mechanisms underlying the effects of stress on 
tumorigenesis has recently been reviewed. During chronic 
stress, the activation of β1- and β2-ARs by elevated levels 
of NE and E promote throught Gs subunits an increasing 
of cyclic AMP (cAMP) that induces the activation of 
Protein Kinase A (PKA). As a consequence, PKA can 
phosphorylate several proteins including cAMP response 
element-binding protein (CREB), Activating transcription 
factors (ATF), (Signal transducer and activator of 
transcription-3) STAT-3, globin transcription factor-1 
(GATA-1) and Src family kinases all known to trigger 
pro-tumorigenic pathways that sustain cellular 
proliferation, escape from apoptosis, migration and 
invasion, epithelial–mesenchymal transition (EMT) and 
pre-metastatic niche formation in different types of cancer 
[3-5]. 
Moreover, a recent work suggests that β-ARs have a 
crucial role in driving neoplastic transformation and 
tumorigenicity and that chronic stress can enhance the 
development of acute lymphoblastic leukemia (ALL) via a 
β-adrenergic signaling pathway with an indirect regulation 
of pre-B leukemic cells behaviors [9]. 
Hara et al. have demonstrated that catecholamines over-
release, promoting the accumulation of DNA damage and 
degradation of tumor suppressor p53 in normal cells, 
could play an important role in cancer development [10]. 
Therefore, chronic exposure to NE and EPI can have 
dramatic effects on DNA damage leading to genomic 
instability and tumorigenesis [11]. The  activation of beta-
adrenergic system has been associated with a upregulation 
of the expression of specific oncogenic signaling 
pathways including Sirtuin-1(Sirt-1) in cervical cancer, 
Src in ovarian cancer and Human Epidermal Growth 
Factor Receptor2 (Her2) in breast cancer [12,13].   
Chronic stress could contribute to alter tumor survival and 
cell death induction, indeed recent in vitro and in vivo 
experiments show that NE enhances proliferation of 
gastric cancer cells and promotes autophagic flux which 
has a tumor-promoting role through AMP-activated 
protein kinase-unc-51-like kinase-1 (AMPK-ULK1) 
pathway [14].  
Moreover NE stimulates cell proliferation and other 
cancerous biological behaviors of pancreatic ductal 
adenocarcinoma (PDAC) cells via β-adrenergic receptor-
dependent activation of p38 mitogen-activated protein 
kinases (p38/MAPK) pathway [15], and at the same time 
was able to inhibit apoptosis and promote cell survival of 
cancer cells, binding β2-ARs in a Notch-1-dependent 
manner [16]. 
Furthermore, EPI reduces the sensitivity to apoptotic cell 
death mechanism in prostate and breast cancer cells 
through interaction with β-ARs and in turn the β-
ARs/cAMP/PKA signaling pathway promotes the 
phosphorylation and consequent inactivation of pro-
apoptotic protein BCL2-associated death promoter (BAD) 
[17] confirming that signaling through β-adrenergic 
receptor can enhance tumor survival through multiple 
intracellular pathways. 
In addition to a role in cell survival and tumor growth, 
chronic stress has also been widely studied for mediating 
metastasis. A sequence of molecular events are used to 
delineate the process including cancer cell local invasion, 
extravasation, micrometastasis formation and colonization 
and  the activation of β-adrenergic system seems to be 
involved in each step of the cancer invasion-metastasis 
cascade [18]. 
Tumor cell adhesion to the components of extracellular 
matrix (ECM) is a determinant key to cell migration, 
invasiveness of cancer cells and their metastatic spread 
from the primary tumor to surrounding tissues. The β-
adrenergic system activation takes part in tumor cell 
adhesion and facilitates migration and invasion.  
Recent work shows that the permanent stimulation of β2-
ARs modulates the integrin-mediated cell adhesion to 
fibronectin through a molecular mechanism that involves 
the exchange protein directly activated by cAMP (Epac) 
and Rap1, a small GTPase belonged to Ras oncogene 
proteins [19]. It has indeed been highlighted that, the 
activation of focal adhesion kinase (FAK) by NE and EPI 
through a β-ARs/PKA/Src dependent pathway protected 
ovarian cancer cells from anoikis, a detachment-induced 
apoptosis from surrounding ECM and neighboring cells 
[20]. 
Regarding the trans-endothelial invasion process, several 
studies suggest that catecholamines may potentiate the 
ability of tumor cells to interact with vascular endothelium 
promoting this process and subsequent metastasis. To 
support this findings an in vitro study has demonstrated 
that NE was able to promote adhesion of breast cancer 
cells to human pulmonary microvascular endothelial cells 
and trans-endothelial invasion involving the susteined 
release of growth-regulated oncogene α (GROα) and β1-
integrin pathway [21].  
In 2015, Barbieri et al. have shown that NE was able to 
influence in vitro and in vivo metastatic potential of 
prostate cancer cells through β2-ARs cell signaling. In fact 
in their experiments the treatment with NE conducted in 
mice xenografted with human hormone-independent 
prostate cancer cell line significantly increased migration 
of these cells from the primary tumor into inguinal lymph 
nodes, consequently to formation of novel metastatic foci. 
Additionally, it has been observed that NE induced 
overexpression of cytokeratin (CK), matrix-
metalloproteinase-2 (MMP-2) and -9 (MMP-9) that was 
paralleled by EMT effects and correlated to higher 
mobility and invasive behaviors of tumor cells [22].  
Taken together, these findings highlight the complex 
mechanisms by which neurotransmitters and chronic 
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stress exert their effect to promote the growth and spread 
of cancer.  
 
 
III. CHRONIC STRESS AND IMMUNE RESPONSE 
 
It is well known that the adrenergic receptors stimulation 
by catecholamines significantly increase the TNF-α 
production, but also increase the concentration of 
cytokines and interleukins  such as IL-6, IL1β, IL10, IL4, 
IFNγ and C-reactive protein (CRP), that accelerate the 
progression of inflammatory diseases [23].  Moreover, the 
sustained release of catecholamines, including 
norepinephrine, promotes the upregulation and activation 
of cAMP response element-binding protein (CREB), 
Phospholipase C, Protein Kinase Cα, Signal transducer 
and activator of transcription 3 (STAT3), the prolactin 
hormone and the prostaglandin E2 (PGE2) synthesis,  all 
known to promote proliferation, migration, angiogenesis 
and apoptosis evasion in several cancers [2-5, 23-25]. 
New scientific evidence has also shown that cancer cells 
release neurotrophic factors (Nerve Growth Factor, NGF 
and Brain-derived Neurotrophic Factor, BDNF) in 
response to catecholamines that, contributing to cancer 
innervation, improve tumorigenesis enriching the tumor 
microenvironment of catecholamines freed from the 
newly formed nerve endings [26]. 
Furthermore, norepinephrine released from nerve 
terminals through the adrenergic receptors is able to 
interact with immune cells. Recently, Ambrèe et al. (2018) 
showed that this property correlates with an altered cell-
mediated immunity in a mouse model of lymphoma. 
Indeed, catecholamines and glucocorticoids have been 
reported to damage the antigen presentation process, 
affect T cell proliferation, and attenuate humoral and cell-
mediated immunity. It has been shown that noradrenaline, 
although is able to increase dendritic cell migration in 
CD8+ T cell-mediated response, greatly reduces their 
overall ability to efficiently present antigens. Furthermore, 
the adrenergic stimulation of dendritic cells enhances Th2-
associated inflammation and Th17 differentiation, 
suppressing at the same time the antitumor activity of NK 
cells and stimulating tumor-associated macrophages to 
produce pro-inflammatory and pro-angiogenic factors 
such as the vascular endothelial growth factor (VEGF) 
and metalloproteinases [27]. 
 
 
IV. CONCLUDING REMARKS 
 
 It is well known as a distressed psychological and 
physiological state that occurs in individuals in the form 
of fear, anxiety, pain and depression, easily manifestable 
with the stressful urban dweller's life, can lead to a 
condition of chronic stress bearing adverse effects on 
cardiovascular and nervous systems and exacerbation of 
autoimmune diseases and like we show in the present 
work, there are increasing scientific evidence that 
underline how chronic psychological stress plays a 
positive role in cancer initiation, progression and cancer 
metastasis and a negative role for anti-tumor immune 
function and therapy response [4]. Moreover, if to the 
stressful urban dweller's life are added unhealthy 
behaviours such as eating and drinking alcohol to excess, 
smoking, abusing drugs or being physically inactive, the 
cancer development risk is further incremented [28-31]. 
At the same time, it is clear that isn't possible to 
completely eliminate stress from everyday life but above 
all from the urban dweller's life, however, much can be 
done to reduce it with benefits for physical health.  
The only valid solution to get out of a condition of chronic 
stress is to change, as far as possible, one's lifestyle. 
How? 
First and foremost, to cope with stress it is important 
being aware of one's sources and causes of stress and only 
in this way is it possible finding a solution. Certainly the 
organization and scheduling of daily, weekly and monthly 
commitments can help to identify priorities and reduce the 
onset of stress situations. Listening to own physical needs, 
trying to take care of own health are undoubtedly the basis 
for having more energy to combat stress conditions, 
combined with the ability to being able to find time every 
day to do pleasant things like practicing a sport or relaxing 
activities. Furthermore, since isolation is one of the factors 
that can greatly amplify the stress condition, learning to 
ask for help by confronting other people can reduce stress. 
Recently, Bonaccio et al. demonstrated how diet can also 
help reduce stress. The researchers evaluated 
psychological resilience, that is a measure of stress coping 
ability, with adherence to the Mediterranean Diet (MD) 
[32]. MD is already considered one of the most worldwide 
healthy dietary patterns thanks to a combination of foods 
rich mainly in antioxidants and anti-inflammatory 
nutrients with protective effects in reducing oxidative and 
inflammatory processes of cells, avoiding DNA damages 
and with contrasting effects on onset, progression and 
regression cancer [33,34]. In addition to these already 
well-known beneficial effects of MD, Bonaccio et al. 
showed that a MD dietary pattern is positively associated 
with higher psychological resilience, compared to 
Western-type diets [32]. 
Furthermore, it is clear that the psychological stress may 
negatively affect cancer therapy. Therefore, a medical 
approach more focused on preserving patient 
psychological wellness, could be able to improve cancer 
prognosis and treatment at the biological level. 
In light of these new findings, in the near future it will be 
of crucial importance conduct information campaigns to 
disseminate the latest scientific evidence in order to 
prevent and minimize the number and the impact on 
health of common daily stressors and at the same time  
comply with a medical approach more focused on 
preserving the patient's psychological well-being in order 
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